share_log
Reuters ·  Apr 26 09:00
Amgen to Submit Teprotumumab Marketing Authorization Application to the European Medicines Agency
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment